Pancreatic Cancer Research

Clinical trialNARecruiting

Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.

Indocyanine Green Fluorescence in Evaluation of Post-resection Pancreatic Remnant Perfusion After Pancreaticoduodenectomy

Outcome
Ongoing
Phase
NA
Status
Recruiting
Study type
Interventional
Start
1 May 2024
Expected end
1 July 2027
Enrollment
60 participants
Sites
1
Primary outcomes
Evaluation of the blood flow in pancreatic remnant with use of ICG
Sponsor
Other
Results posted
No
Last update
21 August 2024

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try